The new funding will help the cluster build on initial milestones and to prepare for clinical applications, particularly in cancer.

Life Line aims to offer Lucent's blood-based testing through its mobile delivery model at urban and rural community health screening events.

Last week, readers were most interested in a story about the conviction of lab owner, formerly an NFL player, for genetic testing fraud.

Among the major issues were tariff policies, reimbursement pathways for multi-cancer early detection tests, and reform of the ...

NEW YORK – Irish diagnostic firm Trinity Biotech announced on Wednesday that it has entered into a $25 million standby equity purchase agreement with an affiliate of its financing partner Yorkville ...

BioAffinity Technologies said on Wednesday that it will run a study of its CyPath Lung test for early lung cancer detection in collaboration with Brooke Army Medical Center (BAMC). CyPath Lung ...

The interferon-gamma release assay for latent tuberculosis infection is designed for use on Diasorin's automated, high-throughput Liaison XL platform.

The precision cancer diagnostics firm Epredia will distribute Mindpeak's AI-based image recognition solutions for clinical diagnostics, research, and pharma development.

The new funding will accelerate the development of a portable diagnostic platform to enhance care for bleeding disorders and critical care medicine.

The cleared assays included point-of-care and home tests for infectious and chronic diseases and drugs of abuse.